hydration benefits glp-1 receptor agonist therapy Agonists in Cardiovascular Diseases: Mechanisms, Clinical Evidence, and Emerging Therapies Therapeutic benefits of glucagon-like peptide-1

Lets break it down simply

Key data point: in the retatrutide fatty-liver study, Sanyal and colleagues (Nature Medicine, 2024) reported liver fat falling 80 to 90 percent over 48 weeks in patients who started with fatty liver disease, a drop tied closely to the weight and belly-fat loss and, in theory, to glucagon-receptor-driven fat burning in the liver

database study, diabetes-related total costs were not significantly different between dulaglutide once weekly and liraglutide once daily, but dulaglutide once weekly was associated with higher costs than exenatide once weekly (59)

Read more February 19, 2024 2 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on

doi:10.1056/nejmoa2301972 9.Douros JD, Mowery SA, Knerr PJ